It’s here—the First-in-Human Simulator!
The accuracy of your preclinical exposure data translation to humans can make or break the success of your Phase 1 clinical trial protocol.
We know the mechanistic translation of preclinical exposure data to humans is vital to your phase 1 clinical trials. You need a first-in-human (FIH) prediction platform with robust functionality and a range of animal and human models to provide as much insight as possible.Learn more about our FIH Simulator
Novice & Advanced Users
Workshops
Online Learning
- Complimentary Introduction to GastroPlus Workshop
- GastroPlus Introductory Workshop – CET (Virtual)
- Advanced GastroPlus DMPK & Clinical Pharmacology Workshop (Virtual)
- PBPK Modeling for FIH Predictions: Virtual Workshop
- GastroPlus Introductory Workshop – Virtual
- GastroPlus Advanced Workshop: Pharmaceutical Development
On-Demand Courses (Now Available)
- DILIsym® Crash Course On Demand
- Transdermal Administration (TCAT™) in GastroPlus®
- Injectables (IM, SQ, IA) in GastroPlus Including Biologics and LAIs
- Ocular Administration (OCAT™) in GastroPlus®
- Pulmonary Administration (PCAT™) in GastroPlus®
- GastroPlus® ADR – 4 Course Bundle (TCAT™ / OCAT™ / OCCAT™ / PCAT™)
- GastroPlus® ADR – 5 Course Bundle (TCAT™ / OCAT™ / OCCAT™ / PCAT™ / Injectables)
View Upcoming Workshops
Meet Us In Person
Conferences
PHUSE US Connect 2024: The Clinical Data Science Conference Feb. 25th-28th Bethesda, MD
- Presentation: An End User’s Perspective of Clinical Dosing Data Used for Population PK / PD Analysis with Non-Linear Mixed Effects Modeling Rebecca Humphrey Presenter:
SOT 63rd Annual Meeting and ToxExpo Mar. 10th-14th Salt Lake City, UT
- Booth #1617
- Attendees: Brett Howell and Pallavi Bhargava
CHI Drug Discovery Chemistry Apr. 1st-4th San Diego, CA
-
- Booth #514
- Attendee: Eric Jamois
View Events Calendar
Take Advantage
Latest Offers
Challenged with budget cuts, rising development costs, and the demand for value-based healthcare?
We can set you up for success.- Unleash the power of AI for early drug discovery
- Streamline PBPK and QSP workflows with our Pulmonary Package
- Train your team during your next consulting project with Consult + Coach
Contact us for Details
Stay Informed
On Demand Webinars
- Mechanistic dissolution data modeling for PBBM introduction: The P-PSD approach
- Ionization Prediction Summit Webinar Series: Session 4 Experimental Aspects of pKa Measurements
- Ionization Prediction Summit Webinar Series: Session 1 Fundamentals of Ionization
- From Target Identification to Novel Lead: How Multi-omics Analysis and AI-driven Drug Design Can Accelerate Early Drug Discovery
View All On Demand Webinars
Can’t Miss
Upcoming Webinars
View All Webinars
Stay Informed
Latest Research
Posters
- Advancing the Multi-Targeted Mechanisms of Action of a Mitochondrial Activator (AXA1125) for Treating NASH Using a Quantitative Systems Pharmacology Model
- ILDsym®, A Quantitative Systems Pharmacology (QSP) Platform, Successfully Simulates Efficacy of Key Treatments for Systemic Sclerosis-Interstitial Lung Disease
- Accelerating a QSP Model of Nonalcoholic Steatohepatitis (NASH) Using the Julia Language
- Mechanistic Representation of NAG Release in Relation to Renal Proximal Tubular Cellular Injury
- Automated covariate selection: SAMBA and COSSAC algorithms
- Development of an Ocular PBPK-PD model to predict drug-mediated intraocular pressure reduction in preclinical species
Read up on New Research